Detalhe da pesquisa
1.
Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
Gut
; 72(2): 226-241, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817555
2.
Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.
Gut
; 72(9): 1651-1663, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918265
3.
Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.
Gut
; 71(4): 676-685, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980610
4.
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.
Gut
; 71(7): 1277-1288, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433583
5.
HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.
Gut
; 69(2): 231-242, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31068366
6.
Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma.
Gut
; 69(6): 1039-1052, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31542774
7.
Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes.
Gastric Cancer
; 21(6): 1064-1070, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915957
8.
Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.
Gut
; 64(5): 707-19, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053715
9.
A densely interconnected genome-wide network of microRNAs and oncogenic pathways revealed using gene expression signatures.
PLoS Genet
; 7(12): e1002415, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22194702
10.
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
Gut
; 61(5): 673-84, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315472
11.
Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression.
Cancer Cell
; 41(12): 2019-2037.e8, 2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890493
12.
Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.
Cancer Discov
; 12(3): 670-691, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642171
13.
Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
Cancer Res
; 82(14): 2538-2551, 2022 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583999
14.
Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer.
Genome Biol
; 22(1): 44, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482911
15.
"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
Cancer Res
; 81(10): 2788-2798, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558338
16.
Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Genome Med
; 13(1): 158, 2021 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635154
17.
Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.
Genome Biol
; 22(1): 167, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074348
18.
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.
J Clin Invest
; 130(6): 3005-3020, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32364535
19.
Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
Cancer Res
; 83(5): 804, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861360
20.
Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer.
Cancer Cell
; 33(1): 137-150.e5, 2018 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29290541